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Abstract 
This study focused on the development and usability evaluation of EnCare diagnostics (ECD) and the Brain Fit Plan (BFP) in healthy older adults, 
cognitively impaired and physically impaired individuals. ECD is proposed as a novel solution to cognitive assessment based on color selection. 
BFP is a novel solution to personalized cognitive stimulation. The study consisted of 2 trials designed to evaluate the usability of the apps. Trial 1 
involved eleven healthy older adults and four older adults with physical impairments who undertook ECD and Mini Mental State Examination 
(MMSE) once per month for four months with only those with physical impairments also completing the BFP daily. Trial 2 involved eight older 
adults diagnosed with early stage dementia who completed MMSE and ECD once per month for six months. In trial 1, 10/11 participants enjoyed 
the trial and managed the usability of the app easily.  A 75% drop out was observed in response to the BFP with issues of dexterity and lack of 
understanding on how to use the technology being the main reasons for lack of compliance. 4/8 participants completed trial 2 with most of the 
participants having no usability issues. This usability study demonstrated that ECD is highly acceptable in both healthy older adults and those with 
early stage dementia when given the shorter versions to accommodate their diagnosis.  The BFP was not suited to this population of participants. 
1. Introduction:  
The Northern Ireland Connected Health Innovation Centre (NI-CHIC) 
was established in June 2013 as part of an initiative to bring together 
Northern Ireland industry, academia and government within the field 
of Connected Health. Lead by Ulster University’s Smart Environment 
Research Group (SERG) and the Nanotechnology and Integrated 
Bioengineering Centre (NIBEC), this centre partners with local 
hardware developers, software developers, clinical organizations and 
care providers to develop novel technology-based interventions to 
assist with the monitoring and management of chronic illness. This 
paper discusses the results of one study completed by NI-CHIC. This 
study focused on the development and usability evaluation of EnCare 
Diagnostics ECD (ECD), originally designed by Redburn Solutions 
[1], and the BrainFit Plan (BFP), originally designed by Fingerprint 
Learning [2]. ECD has been proposed as a potential alternative to the 
Mini-Mental State Examination (MMSE) which is the existing gold 
standard for cognitive assessment. BFP has been proposed as a novel 
approach to personalized cognitive stimulation. The rationale behind 
this study originated from literature documenting potential beneficial 
effects on the aging brain of domain-specific cognitive training [3, 4].,  
The study involved  three user types: cognitively/physically healthy 
older adults, cognitively impaired older adults, and physically 
impaired older adults. ECD proposes that sensory perception of color 
is objective and shared by all, and that color preferences are 
subjective. ECD requires users to first select eight colors in order of 
preference. It then shows users a series of words, and asks them to 
select three colors from eight colors they associate with each word - 
See Patent US 20140067475 A1 [5]. An education version of ECD 
has previously been used within the education sector to identify 
classroom issues with school children, and within the Human 
Resources sector [6]. This study facilitated the development of a 
mobile app version of ECD, in addition to a usability trial of ECD in 
older adults suffering from early stage dementia. The mini mental 
state examination (MMSE) was completed alongside ECD in this 
usability trial (trial 2). ECD usability was also assessed in two other 
cohorts: healthy older adults and older adults with physical 
impairments in another trial (trial 1). 
The BFP facilitates prescribed cognitive stimulation based 
on user preferences. Users are presented with a questionnaire which 
collects data about a user’s learning preferences. The app then 
recommends a series of cognitive stimulation activities, 
predominantly in the form of freely available mobile apps including 
Chess, Sudoku, mathematics puzzles, and jigsaws, and recommends 
the user perform a subset of these tasks twice per day. The usability of 
this solution was evaluated in a trial involving older adults receiving 
long term domiciliary care for physical impairment (trial 1). 
 
2. Methods and Materials:  
The Android platform was chosen as the basis for both the ECD and 
BFP apps. Android was chosen due to its high market share and ease 
of publishing to the Google Play store. In Q2 of 2016, Android had a 
global market share of 87.6%. This is significantly higher than other 
popular mobile platforms including iOS (11.7%) and Windows Phone 
(0.4%). [6]. 
The requirements gathering process for both apps began with 
completing a full assessment of the existing web-based 
implementations of ECD and BFP, and creating a software 
requirements specification for each app using the IEEE format STD 
830-1993. Apps recommended as the cognitive stimulation activities 
were selected by assessing existing apps available on the Google Play 
store, and assessing their usability in terms of simplicity of use, size 
of on-screen elements, and presence of advertisements. BFP and ECD 
were developed in iterative phases, which involved regularly sharing 
updated versions of the apps with the project consortium as new 
features were implemented. This facilitated rapid feedback and 
amendments where necessary during the development process. 
Distribution of app updates was facilitated by placing the apps on the 
Google Play store as private beta versions which were accessible by 
the project consortium. Once the majority of app functionality was 
implemented, the apps were demonstrated to care staff from a local 
domiciliary care provider in order to receive feedback on amendments 
for maximising app usability.  
A. Trials 
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The study consisted of 2 trials designed to evaluate the usability of the 
apps. Both trials were granted ethical approval by The Office for 
Research Ethics Committees (Northern Ireland) [Ref Nos. trial 
1:15/NI/0224, trial 2:15/NI/0166]. All participants provided informed 
written consent prior to participation.  
Trial 1 involved eleven healthy individuals, (60 years and 
older with no obvious cognitive issues) recruited through the Engage 
With Age community development partnership and four individuals 
with physical impairments recruited through a local domiciliary care 
provider. These physical impairments would not inhibit their use of 
the app with colour blindness, total blindness and physical inability to 
hold the app being included in the exclusion criteria (see table 1). 
Physical impairments included a range of manifestations. These 
impairments required daily carer intervention in order to assist with 
activities of daily living. These physical impairments included stroke, 
limiting movement on one side of the body, and general mobility 
limitations requiring carer assistance for movement throughout the 
home. This trial had a duration of 4 months, and involved ECD and 
MMSE assessment once per month, supervised by a health scientist. 
The participants recruited from the domiciliary care company were 
also asked to interact with BFP twice per day which was to be 
supervised by the domiciliary care staff during visits. It was envisaged 
that during these 15 minutes visits the carer would help the individual 
to use the BFP in order to complete their cognitive stimulation 
activities. For this reason, each of the carers recruited onto the trial 
underwent training on how to use the BFP and to operate the cognitive 
stimulation tasks offered to the participants. This occurred over 2 
occasions and consent was taken from each carer involved in the trial 
to attend a focus group upon completion of the trial to gain their 
opinions on the burden on carer time as a result. 
Trial 2 involved eight individuals diagnosed with early 
stage dementia as assessed using the MMSE screening tool and who 
fulfilled the inclusion criterion (see Table 1, trial 2) were recruited 
from the Alzheimer’s Society. This trial had a duration of 6 months, 
involving once per month MMSE assessment and once per month 
ECD completion. Table 1 provides an overview of the inclusion and 
exclusion criteria for both trials. 
 
Table 1: Inclusion / Exclusion Criteria 
 
Trial 1 
Inclusion Criteria Exclusion Criteria 
- Healthy older adults with 
expected mild cognitive 
impairment through aging 
(male or female) who may 
need physical help but not 
mental help. 
- Healthy older adults over the 
age of 60 years 
- Access to a carer or family 
member who is familiar with 
smart phone and/or tablet 
technologies 
- Healthy older adults deemed 
psychologically fit to make 
responses to questions and 
carry out cognitive 
stimulation tasks and give 
informed consent (as assessed 
by the participant 
identification centre and also 
by the researcher taking 
consent) 
- Individuals less than 60 years 
of age 
- Individuals deemed 
psychologically unfit to make 
responses to questions or 
carry out cognitive stimulation 
tasks and give informed 
consent (as assessed by the 
participant identification 
centre and also by the 
researcher taking consent) 
- Individuals who do not speak 
or understand English 
- Individuals with a medical 
condition that would prevent 
them from being physically 
able to hold, see and touch the 
mobile application 
- Individuals who understand 
English 
- Healthy older adults who have 
the physical ability to hold, 
see and touch the mobile 
application 
Trial 2 
Inclusion Criteria Exclusion Criteria 
- Individuals with a clinical 
diagnosis of early stage 
dementia/MMSE score of 
around 24 (range of 21-26) 
(male or female) that may 
need physical help but not 
mental help 
- Individuals deemed 
psychologically fit to make 
responses to questions and 
give informed consent (as 
assessed by the participant 
identification centre and also 
by the researcher taking 
consent)    
- Individuals who understand 
English 
- Individuals who have the 
physical ability to hold, see 
(including color blindness) 
and touch the mobile 
application 
- Individuals with an MMSE 
score of lower than 21 
- Individuals deemed 
psychologically unfit to make 
responses to questions or give 
informed consent (as assessed 
by the participant 
identification centre and also 
by the researcher taking 
consent) 
- Individuals who do not speak 
or understand English 
- Individuals with a medical 
condition that would prevent 
them from being physically 
able to hold, see (including 
color blindness) and touch the 
mobile application 
 
Participants recruited from the domiciliary care company were 
provided with a study pack containing all of the necessary equipment 
for the trial. The key component of the pack was a Nexus 9 tablet, 
upon which both the ECD and BFP apps were deployed. The HTC 
Nexus 9 tablet was chosen due to its support for the Android platform 
in addition to a suitable screen size (8.90” diagonally) for the study 
participants who were older adults with vision and dexterity 
impairments. Originally, the HTC Nexus 7 (screen size: 7.02”) was 
chosen, however feedback from the staff of the domiciliary care 
provider suggested that this device would be too small for the end 
users due to vision and dexterity limitations. Participants’ user 
accounts were limited to only allow access to the ECD and BFP apps, 
removing the opportunity for accidental app removal, installation, or 
web browsing. Participants were also provided with a wireless SIM 
adaptor to provide Wifi access via. 3G, and a stylus to maximise 
usability of the touch screen interface. Finally, a hardcopy of a user 
guide was provided which included images detailing the steps 
required to turn on the device, charge the device, log in to the user 
account, and open and use the apps.  
B. Usability Assessment  
It was planned that the carer would supervise and address any 
problems that were experienced by the participants. Usability of the 
ECD was assessed during each monthly visit with each participant. 
This assessment involved a health scientist observing app interaction.  
3. Results: 
3a. Participant Recruitment, Follow up and Drop Out Rate 
In trial 1, the recruitment rate was lower than anticipated through the 
privately run domiciliary care provider resulting in only n = 4 
participants being deemed to meet the inclusion criteria.  All 4 
participants (2 male and 2 female) completed the initial activity 
survey. At the beginning of the 4-month period, one participant was 
withdrawn from the trial due to the tasks being too onerous.  Two 
participants passed away near the end of the four month test period, 
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leaving one to complete the trial (75% dropout). The main issues 
reported for this initial participant were: 1. The size of the tablet being 
too small resulting in text being too small to read; 2. A high level of 
dexterity being required for some tasks such as crosswords which was 
not feasible; 3. Inability to work the tablet itself through lack of 
understanding.  Issues that were reported by the other three 
participants were similar to those reported above.  The issue of a high 
level of dexterity was partly aided by ability to use a stylus but one 
participant only had use of one arm due to stroke so this did not 
resolve the issue. One participant therefore provided 4/4 sets of 
outcomes, one participant provided 3/4 sets of outcomes, one 
participant provided 2/4 sets of outcomes and one participant was 
withdrawn from the study. This participant was deemed unsuitable on 
attending their 2 week follow-up appointment to check progress.  
11 healthy older adults (9 female,  2 male; mean age: 74years) were 
recruited through the Engage with Age community development 
partnership to complete the ECD assessment once per month only. All 
of the 11 engaged with the trial and all but one completed the trial 
(9% dropout). The one who dropped out did so at the final time point 
resulting in ten full sets of follow-up data and one participant 
providing 4/5 sets of outcomes. This participant had impaired eyesight 
and needed some assistance at times with reading out the words due to 
the text being too small. All other 10 participants stated they enjoyed 
the trial and managed the usability of the app easily. 
Five carers who had regular visits with the trial participants 
agreed to be involved in the trial. It was planned that the carers would 
be involved in the design and development process, as well as support 
and encourage the participant with usage of the app. Whilst the carers 
did help to inform the development of the app, on commencement of 
the trial, it soon became apparent that through lack of time and 
inability to use the technology, there was a very low level of 
engagement with the participants despite the training they had 
received.  
In trial 2,   
N = 8 participants (4 female, 4 male, mean age: 82years)were 
recruited through the Alzheimer’s society. These individuals had a 
diagnosis of early stage dementia but no obvious physical disabilities. 
4/8 participants provided 6/6 sets of outcomes, one participant 
provided 5/6 sets of outcomes, one provided 4/6 sets of outcomes, one 
provided 3/6 sets of outcomes and one provided only 2/6 sets of 
outcomes. Two participants were withdrawn from the study as they 
were deemed incapable of continued consent to continue the trial as 
their MMSE score had dropped below the range that was deemed 
acceptable to continue the study. The burden on the individual to carry 
out the test was also classed as being too great.  
3b. Usability & Acceptability of Brain Fit Plan 
The majority of participants expressed dexterity limitations associated 
with ageing despite having no formal diagnosis of conditions affecting 
motor control. These dexterity limitations, combined with a lack of 
familiarity with touch screen technology, manifested in frequent 
accidental screen presses. For example, to hold the tablet comfortably, 
users often grasped it in such a way that their thumbs rested on the 
touch screen. Additionally, when using their index finger to select on-
screen items, instability in movement resulted in occasionally 
selecting unintended items, and other areas of their hand would 
occasionally accidentally touch the screen. The frequency of these 
accidental touches was reduced through the use of a stylus, which 
every user preferred. In this trial, off the shelf apps were used to 
provide the cognitive stimulation prescribed by BFP. While every 
effort was taken to ensure the most suitable apps were selected, many 
of the apps relied on UI elements that were too small for use by those 
with limited dexterity and eyesight, or relied on the use of a stylus. 
3c. Adverse events related to brain training 
Adverse events associated with this trial were limited. The only 
notable adverse event was occasional frustration experienced by 2/4 
of the participants. This frustration was caused by a desire to complete 
the brain training tasks, but occasionally struggling due to the 
aforementioned dexterity limitations as well as a lack of ability to 
work the technology.  
 
4. Discussion: The main goal of trial 1 was not to assess the 
effectiveness of brain training on cognitive state but to assess the 
usability of the approach before deployment to a larger patient 
population over an extended period of time, which will focus on 
assessment of impact. Both the carers and the participants were keen 
to engage with this novel technology however, results obtained from 
this trial suggest that this is not a feasible environment for this 
technology to be utilised due to the carer not having time or resources 
to promote participant engagement. The initial plan was to target users 
that receive domiciliary care twice per day and therefore engage with 
the technology in the same pattern however this was not feasible. The 
staff were keen to be involved in the design and development process 
of both apps, and provided useful feedback on the appropriateness of 
the apps for their client population, but did not supervise usage of 
BFP during each visit. This was due to time limitations, workload, 
and the fact one client would receive visits from many different care 
staff. The lack of ability by the participants to use the tablet and 
therefore reduce engagement may have been resolved should the 
participants carer have been more involved. For this particular 
population, bigger tablets, with easier tasks or user friendly versions 
would be better suited. There is an opportunity for future studies to 
investigate the use of “All in one” touch screen computers which offer 
several characteristics that may mitigate the usability issues found 
within this trial. For example, such devices are supplied with larger 
displays, catering for larger on screen user interface components and 
therefore minimizing the impact of smaller inaccuracies in physical 
interaction. Additionally, these devices are typically provided with a 
stand which allows the device to sit upright on a table without being 
held. This may reduce the number of accidental interactions and 
would maximize usability by those with dexterity limitations. 
We suggest looking further into the performance metrics of the 
cognitive stimulation tasks in order to gain a better understanding of 
cognitive ability and therefore possibly identify population groups 
who would benefit most from this type of technology. The BFP 
metrics were not analysed for the purpose of this paper due to 
compliance being so low as most users struggled with the technology. 
However, most were keen to take part and expressed an interest in 
using an adapted version of the technology to better suit their physical 
needs. 
The main goal of trial 2 was to assess the usability of the 
ECD software and its possible validity to assess cognitive state in 
comparison to the widely used MMSE. Should this tool be readily 
accepted by such populations, it could be used to assess the 
effectiveness of various interventions on cognitive state.  Some of the 
early stage dementia participants, with a lower MMSE score, 
struggled to complete the ECD assessment without some help.  This 
added on significant amounts of time to the assessment visit.  It soon 
became apparent that a shorter test would resolve this issue.  A degree 
of subjectivity was introduced from the outcome assessor from the 
necessity to make a judgement on which version was applicable for 
the participant.  Three versions were developed depending on the 
researcher's judgment. This resulted in those participants who were 
struggling to complete the trial.  This subjectivity could be lessened 
with the production of guidelines based on the individuals MMSE 
score in this particular population group. All other feedback from both 
groups of participants was positive. 
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5. Conclusion: The ECD software proved to be a feasible and readily 
accepted tool to assess cognitive state in the population groups 
investigated, namely healthy older adults and also those individuals 
with early stage dementia due to the development of three versions to 
suit the individual being assessed.    
The preliminary BFP trial would suggest that this 
technology as a potential service to this patient population isn’t 
feasible due to the high degree of help that is required from the carer 
for the participant to successfully use the technology.  We recommend 
this technology might be more suitable in a patient population with 
less advanced physical and cognitive needs or individuals with a 
dedicated private carer who could provide the extra support needed. 
 Further work will investigate the potential of using larger, 
fixed position “All in one” touch screen computers as an alternative to 
portable tablets, which may mitigate several of the usability issues 
discovered in the study.  
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